Effects of antivascular endothelial growth factor drug treatment on changes in vitreomacular interface, intraocular pressure and visual acuity of patients with age-related macular degeneration

Minerva Med. 2023 Aug;114(4):529-530. doi: 10.23736/S0026-4806.22.08047-8. Epub 2022 Mar 25.

Authors

Jihong Wang¹, Jia Li², Yeqin Shi², Ting Chu², Haicui Shen², Xin Qian², Chun Wang²

Affiliations

¹ Department of Ophthalmology, Affiliated Hospital of Jiangnan University, Wuxi, China - wangjhahju@uic-edu.cn.
² Department of Ophthalmology, Affiliated Hospital of Jiangnan University, Wuxi, China.

PMID: 35332759
DOI: 10.23736/S0026-4806.22.08047-8

No abstract available

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Endothelial Growth Factors* / therapeutic use
Follow-Up Studies
Humans
Intraocular Pressure
Macular Degeneration* / drug therapy
Retrospective Studies
Tomography, Optical Coherence
Treatment Outcome
Visual Acuity

Substances

Endothelial Growth Factors
Angiogenesis Inhibitors